The Indian government has confirmed that Rs 5,210 crore (approximately $625 million) has been invested under the Production Linked Incentive (PLI) scheme for Key Starting Materials (KSM), drug intermediates, and…
India's drug regulator, the Central Drugs Standard Control Organisation (CDSCO), is building an end-to-end digital drug regulatory platform that the Drug Controller General of India (DCGI) expects to launch in…
India's drug regulator is signalling a major shift in how it oversees the pharmaceutical industry — moving from a uniform, checklist-based inspection model toward a smarter, risk-based approach that could…
When you are buying generic medicines from India, one of the most important quality signals you can check is the WHO-GMP (World Health Organization Good Manufacturing Practice) certificate. But what…